img

Global Thrombin Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Thrombin Market Insights, Forecast to 2034

Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
Global Thrombin market is expected to reach to US$ 585.1 million in 2024, with a positive growth of %, compared with US$ 565 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Thrombin industry is evaluated to reach US$ 704.7 million in 2029. The CAGR will be 3.2% during 2024 to 2029.
Globally, Thrombin key manufacturers include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc. Takeda, Bayer, CSL are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Thrombin were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Thrombin market and estimated to attract more attentions from industry insiders and investors.
Thrombin can be divided into Powder Form, Solution Form, Pad Form and Spray Kits, etc. Powder Form is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Thrombin is widely used in various fields, such as Hospitals, Diagnostics & Clinics and Academic and Research Institute,, etc. Hospitals provides greatest supports to the Thrombin industry development. In 2022, global % sales of Thrombin went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Thrombin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Thrombin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Segment by Type
Powder Form
Solution Form
Pad Form
Spray Kits
Others

Segment by Application


Hospitals
Diagnostics & Clinics
Academic and Research Institute

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Thrombin plant distribution, commercial date of Thrombin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Thrombin introduction, etc. Thrombin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Thrombin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Thrombin Product Introduction
1.2 Market by Type
1.2.1 Global Thrombin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Powder Form
1.2.3 Solution Form
1.2.4 Pad Form
1.2.5 Spray Kits
1.2.6 Others
1.3 Market by Application
1.3.1 Global Thrombin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Thrombin Sales Estimates and Forecasts 2018-2029
2.2 Global Thrombin Revenue by Region
2.2.1 Global Thrombin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Thrombin Revenue by Region (2018-2024)
2.2.3 Global Thrombin Revenue by Region (2024-2029)
2.2.4 Global Thrombin Revenue Market Share by Region (2018-2029)
2.3 Global Thrombin Sales Estimates and Forecasts 2018-2029
2.4 Global Thrombin Sales by Region
2.4.1 Global Thrombin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Thrombin Sales by Region (2018-2024)
2.4.3 Global Thrombin Sales by Region (2024-2029)
2.4.4 Global Thrombin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Thrombin Sales by Manufacturers
3.1.1 Global Thrombin Sales by Manufacturers (2018-2024)
3.1.2 Global Thrombin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Thrombin in 2022
3.2 Global Thrombin Revenue by Manufacturers
3.2.1 Global Thrombin Revenue by Manufacturers (2018-2024)
3.2.2 Global Thrombin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Thrombin Revenue in 2022
3.3 Global Key Players of Thrombin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Thrombin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Thrombin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Thrombin, Product Offered and Application
3.8 Global Key Manufacturers of Thrombin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Thrombin Sales by Type
4.1.1 Global Thrombin Historical Sales by Type (2018-2024)
4.1.2 Global Thrombin Forecasted Sales by Type (2024-2029)
4.1.3 Global Thrombin Sales Market Share by Type (2018-2029)
4.2 Global Thrombin Revenue by Type
4.2.1 Global Thrombin Historical Revenue by Type (2018-2024)
4.2.2 Global Thrombin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Thrombin Revenue Market Share by Type (2018-2029)
4.3 Global Thrombin Price by Type
4.3.1 Global Thrombin Price by Type (2018-2024)
4.3.2 Global Thrombin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Thrombin Sales by Application
5.1.1 Global Thrombin Historical Sales by Application (2018-2024)
5.1.2 Global Thrombin Forecasted Sales by Application (2024-2029)
5.1.3 Global Thrombin Sales Market Share by Application (2018-2029)
5.2 Global Thrombin Revenue by Application
5.2.1 Global Thrombin Historical Revenue by Application (2018-2024)
5.2.2 Global Thrombin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Thrombin Revenue Market Share by Application (2018-2029)
5.3 Global Thrombin Price by Application
5.3.1 Global Thrombin Price by Application (2018-2024)
5.3.2 Global Thrombin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Thrombin Market Size by Type
6.1.1 US & Canada Thrombin Sales by Type (2018-2029)
6.1.2 US & Canada Thrombin Revenue by Type (2018-2029)
6.2 US & Canada Thrombin Market Size by Application
6.2.1 US & Canada Thrombin Sales by Application (2018-2029)
6.2.2 US & Canada Thrombin Revenue by Application (2018-2029)
6.3 US & Canada Thrombin Market Size by Country
6.3.1 US & Canada Thrombin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Thrombin Sales by Country (2018-2029)
6.3.3 US & Canada Thrombin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Thrombin Market Size by Type
7.1.1 Europe Thrombin Sales by Type (2018-2029)
7.1.2 Europe Thrombin Revenue by Type (2018-2029)
7.2 Europe Thrombin Market Size by Application
7.2.1 Europe Thrombin Sales by Application (2018-2029)
7.2.2 Europe Thrombin Revenue by Application (2018-2029)
7.3 Europe Thrombin Market Size by Country
7.3.1 Europe Thrombin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Thrombin Sales by Country (2018-2029)
7.3.3 Europe Thrombin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Thrombin Market Size
8.1.1 China Thrombin Sales (2018-2029)
8.1.2 China Thrombin Revenue (2018-2029)
8.2 China Thrombin Market Size by Application
8.2.1 China Thrombin Sales by Application (2018-2029)
8.2.2 China Thrombin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Thrombin Market Size by Type
9.1.1 Asia Thrombin Sales by Type (2018-2029)
9.1.2 Asia Thrombin Revenue by Type (2018-2029)
9.2 Asia Thrombin Market Size by Application
9.2.1 Asia Thrombin Sales by Application (2018-2029)
9.2.2 Asia Thrombin Revenue by Application (2018-2029)
9.3 Asia Thrombin Sales by Region
9.3.1 Asia Thrombin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Thrombin Revenue by Region (2018-2029)
9.3.3 Asia Thrombin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Thrombin Market Size by Type
10.1.1 Middle East, Africa and Latin America Thrombin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Thrombin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Thrombin Market Size by Application
10.2.1 Middle East, Africa and Latin America Thrombin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Thrombin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Thrombin Sales by Country
10.3.1 Middle East, Africa and Latin America Thrombin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Thrombin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Thrombin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bayer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 CSL Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Grifols
11.4.1 Grifols Company Information
11.4.2 Grifols Overview
11.4.3 Grifols Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Grifols Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Grifols Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Information
11.5.2 GE Healthcare Overview
11.5.3 GE Healthcare Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 GE Healthcare Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GE Healthcare Recent Developments
11.6 Hualan Biological
11.6.1 Hualan Biological Company Information
11.6.2 Hualan Biological Overview
11.6.3 Hualan Biological Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hualan Biological Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Biological Recent Developments
11.7 Haematologic Technologies Inc.
11.7.1 Haematologic Technologies Inc. Company Information
11.7.2 Haematologic Technologies Inc. Overview
11.7.3 Haematologic Technologies Inc. Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Haematologic Technologies Inc. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Haematologic Technologies Inc. Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Pfizer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Octapharma
11.9.1 Octapharma Company Information
11.9.2 Octapharma Overview
11.9.3 Octapharma Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Octapharma Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Octapharma Recent Developments
11.10 Omrix Biopharmaceuticals Ltd.
11.10.1 Omrix Biopharmaceuticals Ltd. Company Information
11.10.2 Omrix Biopharmaceuticals Ltd. Overview
11.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Omrix Biopharmaceuticals Ltd. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Omrix Biopharmaceuticals Ltd. Recent Developments
11.11 Shanghai RAAS
11.11.1 Shanghai RAAS Company Information
11.11.2 Shanghai RAAS Overview
11.11.3 Shanghai RAAS Thrombin Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Shanghai RAAS Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai RAAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Thrombin Industry Chain Analysis
12.2 Thrombin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Thrombin Production Mode & Process
12.4 Thrombin Sales and Marketing
12.4.1 Thrombin Sales Channels
12.4.2 Thrombin Distributors
12.5 Thrombin Customers
13 Market Dynamics
13.1 Thrombin Industry Trends
13.2 Thrombin Market Drivers
13.3 Thrombin Market Challenges
13.4 Thrombin Market Restraints
14 Key Findings in The Global Thrombin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Thrombin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Powder Form
Table 3. Major Manufacturers of Solution Form
Table 4. Major Manufacturers of Pad Form
Table 5. Major Manufacturers of Spray Kits
Table 6. Major Manufacturers of Others
Table 7. Global Thrombin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Thrombin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Thrombin Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Thrombin Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Thrombin Revenue Market Share by Region (2018-2024)
Table 12. Global Thrombin Revenue Market Share by Region (2024-2029)
Table 13. Global Thrombin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Thrombin Sales by Region (2018-2024) & (MT)
Table 15. Global Thrombin Sales by Region (2024-2029) & (MT)
Table 16. Global Thrombin Sales Market Share by Region (2018-2024)
Table 17. Global Thrombin Sales Market Share by Region (2024-2029)
Table 18. Global Thrombin Sales by Manufacturers (2018-2024) & (MT)
Table 19. Global Thrombin Sales Share by Manufacturers (2018-2024)
Table 20. Global Thrombin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Thrombin Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Thrombin, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Thrombin Price by Manufacturers 2018-2024 (USD/Kg)
Table 24. Global Thrombin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Thrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin as of 2022)
Table 26. Global Key Manufacturers of Thrombin, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Thrombin, Product Offered and Application
Table 28. Global Key Manufacturers of Thrombin, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Thrombin Sales by Type (2018-2024) & (MT)
Table 31. Global Thrombin Sales by Type (2024-2029) & (MT)
Table 32. Global Thrombin Sales Share by Type (2018-2024)
Table 33. Global Thrombin Sales Share by Type (2024-2029)
Table 34. Global Thrombin Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Thrombin Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Thrombin Revenue Share by Type (2018-2024)
Table 37. Global Thrombin Revenue Share by Type (2024-2029)
Table 38. Thrombin Price by Type (2018-2024) & (USD/Kg)
Table 39. Global Thrombin Price Forecast by Type (2024-2029) & (USD/Kg)
Table 40. Global Thrombin Sales by Application (2018-2024) & (MT)
Table 41. Global Thrombin Sales by Application (2024-2029) & (MT)
Table 42. Global Thrombin Sales Share by Application (2018-2024)
Table 43. Global Thrombin Sales Share by Application (2024-2029)
Table 44. Global Thrombin Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Thrombin Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Thrombin Revenue Share by Application (2018-2024)
Table 47. Global Thrombin Revenue Share by Application (2024-2029)
Table 48. Thrombin Price by Application (2018-2024) & (USD/Kg)
Table 49. Global Thrombin Price Forecast by Application (2024-2029) & (USD/Kg)
Table 50. US & Canada Thrombin Sales by Type (2018-2024) & (MT)
Table 51. US & Canada Thrombin Sales by Type (2024-2029) & (MT)
Table 52. US & Canada Thrombin Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Thrombin Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Thrombin Sales by Application (2018-2024) & (MT)
Table 55. US & Canada Thrombin Sales by Application (2024-2029) & (MT)
Table 56. US & Canada Thrombin Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Thrombin Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Thrombin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Thrombin Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Thrombin Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Thrombin Sales by Country (2018-2024) & (MT)
Table 62. US & Canada Thrombin Sales by Country (2024-2029) & (MT)
Table 63. Europe Thrombin Sales by Type (2018-2024) & (MT)
Table 64. Europe Thrombin Sales by Type (2024-2029) & (MT)
Table 65. Europe Thrombin Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Thrombin Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Thrombin Sales by Application (2018-2024) & (MT)
Table 68. Europe Thrombin Sales by Application (2024-2029) & (MT)
Table 69. Europe Thrombin Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Thrombin Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Thrombin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Thrombin Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Thrombin Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Thrombin Sales by Country (2018-2024) & (MT)
Table 75. Europe Thrombin Sales by Country (2024-2029) & (MT)
Table 76. China Thrombin Sales by Type (2018-2024) & (MT)
Table 77. China Thrombin Sales by Type (2024-2029) & (MT)
Table 78. China Thrombin Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Thrombin Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Thrombin Sales by Application (2018-2024) & (MT)
Table 81. China Thrombin Sales by Application (2024-2029) & (MT)
Table 82. China Thrombin Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Thrombin Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Thrombin Sales by Type (2018-2024) & (MT)
Table 85. Asia Thrombin Sales by Type (2024-2029) & (MT)
Table 86. Asia Thrombin Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Thrombin Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Thrombin Sales by Application (2018-2024) & (MT)
Table 89. Asia Thrombin Sales by Application (2024-2029) & (MT)
Table 90. Asia Thrombin Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Thrombin Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Thrombin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Thrombin Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Thrombin Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Thrombin Sales by Region (2018-2024) & (MT)
Table 96. Asia Thrombin Sales by Region (2024-2029) & (MT)
Table 97. Middle East, Africa and Latin America Thrombin Sales by Type (2018-2024) & (MT)
Table 98. Middle East, Africa and Latin America Thrombin Sales by Type (2024-2029) & (MT)
Table 99. Middle East, Africa and Latin America Thrombin Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Thrombin Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Thrombin Sales by Application (2018-2024) & (MT)
Table 102. Middle East, Africa and Latin America Thrombin Sales by Application (2024-2029) & (MT)
Table 103. Middle East, Africa and Latin America Thrombin Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Thrombin Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Thrombin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Thrombin Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Thrombin Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Thrombin Sales by Country (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Thrombin Sales by Country (2024-2029) & (MT)
Table 110. Takeda Company Information
Table 111. Takeda Description and Major Businesses
Table 112. Takeda Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 113. Takeda Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Takeda Recent Developments
Table 115. Bayer Company Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 118. Bayer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bayer Recent Developments
Table 120. CSL Company Information
Table 121. CSL Description and Major Businesses
Table 122. CSL Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 123. CSL Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. CSL Recent Developments
Table 125. Grifols Company Information
Table 126. Grifols Description and Major Businesses
Table 127. Grifols Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 128. Grifols Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Grifols Recent Developments
Table 130. GE Healthcare Company Information
Table 131. GE Healthcare Description and Major Businesses
Table 132. GE Healthcare Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 133. GE Healthcare Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. GE Healthcare Recent Developments
Table 135. Hualan Biological Company Information
Table 136. Hualan Biological Description and Major Businesses
Table 137. Hualan Biological Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 138. Hualan Biological Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Hualan Biological Recent Developments
Table 140. Haematologic Technologies Inc. Company Information
Table 141. Haematologic Technologies Inc. Description and Major Businesses
Table 142. Haematologic Technologies Inc. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 143. Haematologic Technologies Inc. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Haematologic Technologies Inc. Recent Developments
Table 145. Pfizer Company Information
Table 146. Pfizer Description and Major Businesses
Table 147. Pfizer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 148. Pfizer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Pfizer Recent Developments
Table 150. Octapharma Company Information
Table 151. Octapharma Description and Major Businesses
Table 152. Octapharma Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 153. Octapharma Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Octapharma Recent Developments
Table 155. Omrix Biopharmaceuticals Ltd. Company Information
Table 156. Omrix Biopharmaceuticals Ltd. Description and Major Businesses
Table 157. Omrix Biopharmaceuticals Ltd. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 158. Omrix Biopharmaceuticals Ltd. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Omrix Biopharmaceuticals Ltd. Recent Developments
Table 160. Shanghai RAAS Company Information
Table 161. Shanghai RAAS Description and Major Businesses
Table 162. Shanghai RAAS Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 163. Shanghai RAAS Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Shanghai RAAS Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Thrombin Distributors List
Table 168. Thrombin Customers List
Table 169. Thrombin Market Trends
Table 170. Thrombin Market Drivers
Table 171. Thrombin Market Challenges
Table 172. Thrombin Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombin Product Picture
Figure 2. Global Thrombin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Thrombin Market Share by Type in 2022 & 2029
Figure 4. Powder Form Product Picture
Figure 5. Solution Form Product Picture
Figure 6. Pad Form Product Picture
Figure 7. Spray Kits Product Picture
Figure 8. Others Product Picture
Figure 9. Global Thrombin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Thrombin Market Share by Application in 2022 & 2029
Figure 11. Hospitals
Figure 12. Diagnostics & Clinics
Figure 13. Academic and Research Institute
Figure 14. Thrombin Report Years Considered
Figure 15. Global Thrombin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Thrombin Revenue 2018-2029 (US$ Million)
Figure 17. Global Thrombin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Thrombin Revenue Market Share by Region (2018-2029)
Figure 19. Global Thrombin Sales 2018-2029 ((MT)
Figure 20. Global Thrombin Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Thrombin Sales YoY (2018-2029) & (MT)
Figure 22. US & Canada Thrombin Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Thrombin Sales YoY (2018-2029) & (MT)
Figure 24. Europe Thrombin Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Thrombin Sales YoY (2018-2029) & (MT)
Figure 26. China Thrombin Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Thrombin Sales YoY (2018-2029) & (MT)
Figure 28. Asia (excluding China) Thrombin Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Thrombin Sales YoY (2018-2029) & (MT)
Figure 30. Middle East, Africa and Latin America Thrombin Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Thrombin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Thrombin in the World: Market Share by Thrombin Revenue in 2022
Figure 33. Global Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Thrombin Sales Market Share by Type (2018-2029)
Figure 35. Global Thrombin Revenue Market Share by Type (2018-2029)
Figure 36. Global Thrombin Sales Market Share by Application (2018-2029)
Figure 37. Global Thrombin Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Thrombin Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Thrombin Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Thrombin Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Thrombin Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Thrombin Revenue Share by Country (2018-2029)
Figure 43. US & Canada Thrombin Sales Share by Country (2018-2029)
Figure 44. U.S. Thrombin Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Thrombin Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Thrombin Sales Market Share by Type (2018-2029)
Figure 47. Europe Thrombin Revenue Market Share by Type (2018-2029)
Figure 48. Europe Thrombin Sales Market Share by Application (2018-2029)
Figure 49. Europe Thrombin Revenue Market Share by Application (2018-2029)
Figure 50. Europe Thrombin Revenue Share by Country (2018-2029)
Figure 51. Europe Thrombin Sales Share by Country (2018-2029)
Figure 52. Germany Thrombin Revenue (2018-2029) & (US$ Million)
Figure 53. France Thrombin Revenue (2018-2029) & (US$ Million)
Figure 54. UK Thrombin Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Thrombin Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Thrombin Revenue (2018-2029) & (US$ Million)
Figure 57. China Thrombin Sales Market Share by Type (2018-2029)
Figure 58. China Thrombin Revenue Market Share by Type (2018-2029)
Figure 59. China Thrombin Sales Market Share by Application (2018-2029)
Figure 60. China Thrombin Revenue Market Share by Application (2018-2029)
Figure 61. Asia Thrombin Sales Market Share by Type (2018-2029)
Figure 62. Asia Thrombin Revenue Market Share by Type (2018-2029)
Figure 63. Asia Thrombin Sales Market Share by Application (2018-2029)
Figure 64. Asia Thrombin Revenue Market Share by Application (2018-2029)
Figure 65. Asia Thrombin Revenue Share by Region (2018-2029)
Figure 66. Asia Thrombin Sales Share by Region (2018-2029)
Figure 67. Japan Thrombin Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Thrombin Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Thrombin Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Thrombin Revenue (2018-2029) & (US$ Million)
Figure 71. India Thrombin Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Thrombin Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Thrombin Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Thrombin Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Thrombin Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Thrombin Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Thrombin Sales Share by Country (2018-2029)
Figure 78. Brazil Thrombin Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Thrombin Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Thrombin Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Thrombin Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Thrombin Revenue (2018-2029) & (US$ Million)
Figure 83. Thrombin Value Chain
Figure 84. Thrombin Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries